• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    DocGo Signs Contract in Mississippi with Major Hospital System to Provide Adult and Pediatric Remote Cardiac Monitoring Services

    12/4/24 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care
    Get the next $DCGO alert in real time by email

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced that its Cardiac RMS subsidiary has signed a new contract with one of the largest hospital systems in Mississippi.

    Under the agreement, in early 2025 Cardiac RMS by DocGo is scheduled to begin providing remote monitoring for nearly 3,000 patients with cardiac implantable electronic devices ("CIEDs"). This new contract marks Cardiac RMS's launch into Mississippi and expands their pediatric customer base – reflecting the company's ability to provide remote monitoring solutions across all age groups in this new geography.

    Mississippi faces high rates of cardiovascular disease, limited access to specialized care in rural areas, and significant healthcare provider shortages that create unique challenges for delivering effective, timely care. Cardiac RMS's remote monitoring will help reduce the need for frequent in-office visits and enable early interventions that can prevent serious complications, while also enhancing clinical efficiency by helping streamline operations, reduce hospital readmissions, and improve patient outcomes.

    "Health systems are increasingly seeking solutions that empower patient-centered care and more effective resource management," said Lee Bienstock, CEO of DocGo. "By partnering with Cardiac RMS, providers can ensure continuous oversight of cardiac device patients of all ages, helping to prevent complications, reduce hospitalizations, and enhance operational efficiency. This collaboration exemplifies how remote patient monitoring can be a vital component of a modern, proactive, value-based care strategy."

    Cardiac RMS by DocGo will provide continuous remote oversight of patients with CIEDs, including pacemakers, implantable cardioverter-defibrillators, implantable heart failure devices, and implantable loop recorders, which require regular monitoring to ensure proper function and to promptly detect any issues.

    Through advanced technology and adaptable services, Cardiac RMS by DocGo continues to elevate the delivery of cardiac care services, helping providers improve outcomes and create seamless patient experiences.

    About Cardiac RMS by DocGo

    Cardiac RMS LLC is a clinical service partner specializing in remote monitoring of cardiac implantable electronic devices (CIEDs), including pacemakers, defibrillators, implantable loop recorders, and heart failure devices. Services also include Virtual Care Management and Remote Physiologic Monitoring (RPM) to support the treatment of chronic conditions. By enhancing care accessibility and streamlining remote care, Cardiac RMS by DocGo empowers providers to deliver proactive, patient-focused solutions that improve outcomes and reduce costs.

    About DocGo

    DocGo is leading the proactive healthcare revolution with an innovative care delivery platform that includes mobile health services, remote patient monitoring and ambulance services. DocGo is helping to reshape the traditional four-wall healthcare system by providing high quality, highly accessible care to patients where and when they need it. DocGo's proprietary technology and relationships with dedicated field staff of certified health professionals elevate the quality of patient care and drive business efficiencies for facilities, hospital networks and health insurance providers. With Mobile Health, DocGo empowers the full promise and potential of telehealth by facilitating healthcare treatment, in tandem with a remote physician, in the comfort of a patient's home or workplace. Together with DocGo's integrated Ambulnz medical transport services, DocGo is bridging the gap between physical and virtual care. For more information, please visit www.docgo.com. To get an inside look on how the proactive healthcare revolution is helping transform healthcare by reducing costs, increasing efficiency and improving outcomes, visit www.proactivecarenow.com.

    Forward-Looking Statements

    This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, regarding, among other things, the Company's plans, strategies, outcomes, and prospects, both business and financial, of the Company, including the provision of services by Cardiac RMS in Mississippi. These statements are based on the beliefs and assumptions of the Company's management. Although the Company believes that its plans, intentions and expectations reflected in or suggested by these forward-looking statements are reasonable, the Company cannot assure you that it will achieve or realize these plans, intentions, outcomes, results or expectations. Accordingly, you should not place undue reliance on such statements. All statements other than statements of historical fact are forward-looking. In some cases, these statements may be preceded by, followed by or include the words "believes," "estimates," "expects," "projects," "forecasts," "may," "might," "will," "should," "could," "can," "would," "design," "potential," "seeks," "plans," "scheduled," "anticipates," "intends" or the negative of these terms or similar expressions. Forward-looking statements are inherently subject to substantial risks, uncertainties and assumptions, many of which are beyond the Company's control, and which may cause the Company's actual results or outcomes, or the timing of results or outcomes, to differ materially from those contained in the Company's forward-looking statements, including, but not limited to the following: the Company's ability to successfully implement its business strategy, including with respect to the provision of services in Mississippi; the Company's reliance on and ability to maintain its contractual relationships with its healthcare provider partners and clients; the Company's ability to compete effectively in a highly competitive industry; the Company's ability to maintain existing contracts, including Cardiac RMS's new contract to provide services in Mississippi; the Company's reliance on government contracts; the Company's ability to effectively manage its growth; the Company's financial performance and future prospects; the Company's ability to deliver on its business strategies or models, plans and goals; the Company's ability to expand geographically; the Company's competitive position and opportunities, including its ability to realize the benefits from its operating model; and other risk factors included in the Company's filings with the Securities and Exchange Commission. The forward-looking statements made in this press release are based on events or circumstances as of the date on which the statements are made. The Company undertakes no obligation to update any forward-looking statements made in this press release to reflect events or circumstances after the date of this press release or to reflect new information or the occurrence of unanticipated events, except as and to the extent required by law.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20241204874763/en/

    Get the next $DCGO alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Q&A

    New
    • What recent development has DocGo announced regarding its Cardiac RMS subsidiary?

      DocGo's Cardiac RMS subsidiary has signed a contract with a large hospital system in Mississippi to provide remote monitoring services.

    • When is Cardiac RMS scheduled to start its new services in Mississippi?

      The contract is set to begin in early 2025, covering nearly 3,000 patients with cardiac implantable electronic devices (CIEDs).

    • What types of devices will Cardiac RMS monitor under the new contract?

      Cardiac RMS will provide continuous remote monitoring for patients with devices like pacemakers and defibrillators, helping detect issues promptly and enhance patient outcomes.

    • How does the new monitoring service aim to address specific healthcare challenges in Mississippi?

      The remote monitoring initiative aims to address Mississippi's high rates of cardiovascular disease, improve access to care, and optimize healthcare resource management.

    • What are the expected benefits of the agreement between Cardiac RMS and the Mississippi hospital system?

      The collaboration promotes proactive, patient-centered care, aims to prevent complications, and supports value-based care strategies.

    Recent Analyst Ratings for
    $DCGO

    DatePrice TargetRatingAnalyst
    5/9/2025Buy → Neutral
    BTIG Research
    2/28/2025$5.00 → $2.85Buy → Hold
    Deutsche Bank
    8/18/2023$15.00Buy
    BTIG Research
    4/21/2023$11.00Overweight
    Cantor Fitzgerald
    4/19/2022$11.00Buy
    Deutsche Bank
    1/19/2022$14.00Buy
    Stifel
    12/21/2021$13.00Buy
    Canaccord Genuity
    12/7/2021$14.00Buy
    Needham
    More analyst ratings

    $DCGO
    SEC Filings

    View All

    SEC Form PRE 14A filed by DocGo Inc.

    PRE 14A - DocGo Inc. (0001822359) (Filer)

    4/10/26 4:05:30 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by DocGo Inc.

    SCHEDULE 13G/A - DocGo Inc. (0001822359) (Subject)

    3/26/26 6:03:49 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    SEC Form S-8 filed by DocGo Inc.

    S-8 - DocGo Inc. (0001822359) (Filer)

    3/17/26 4:36:43 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    DocGo downgraded by BTIG Research

    BTIG Research downgraded DocGo from Buy to Neutral

    5/9/25 8:41:42 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo downgraded by Deutsche Bank with a new price target

    Deutsche Bank downgraded DocGo from Buy to Hold and set a new price target of $2.85 from $5.00 previously

    2/28/25 8:51:46 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    BTIG Research initiated coverage on DocGo with a new price target

    BTIG Research initiated coverage of DocGo with a rating of Buy and set a new price target of $15.00

    8/18/23 7:24:03 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Ethisphere Names DocGo as One of the 2026 World's Most Ethical Companies®

    20th annual recognition honors organizations committed to business integrity through robust ethics, compliance, and governance programs DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled medical transportation and mobile health services, announced today that it has been recognized as one of the 2026 World's Most Ethical Companies® by Ethisphere, a global leader in defining and advancing the standards of ethical business practices. This is DocGo's first time receiving this honor, and the Company is one of only four honorees in the healthcare providers and services category. In 2026, 138 honorees were recognized, spanning 17 countries and 40 indu

    3/18/26 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Announces Fourth Quarter and Full Year 2025 Results

    Company Raises 2026 Revenue and Adjusted EBITDA Guidance due to Customer Expansions, Improved EMS Hiring Rates and Efficiency Initiatives Company Has Initiated a Formal Process to Explore Strategic Alternatives to Maximize Shareholder Value Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Total revenue for the fourth quarter of 2025 was $74.9 million, compared t

    3/16/26 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo to Announce Fourth Quarter and Full Year 2025 Results on Monday, March 16, 2026

    Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled medical transportation and mobile health services, announced today that the Company will release its financial results for the fourth quarter and full year ended December 31, 2025, after the markets close on Monday, March 16, 2025. Management will also host a conference call to discuss these results and its outlook for 2026 at 5:00 p.m. ET on that day. Conference call and webcast details: Monday, March 16, 2026 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) Conference ID: 74028 To access the Call m

    3/2/26 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Burdiek Michael J bought $13,300 worth of shares (10,000 units at $1.33), increasing direct ownership by 2% to 641,560 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/23/25 4:25:30 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Director Burdiek Michael J bought $21,450 worth of shares (15,000 units at $1.43), increasing direct ownership by 2% to 631,560 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/15/25 5:05:47 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Director Klasko Stephen K. M.D. bought $22,350 worth of shares (15,000 units at $1.49) (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    5/14/25 5:42:40 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Bienstock Lee

    4 - DocGo Inc. (0001822359) (Issuer)

    3/31/26 7:57:38 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Chief Executive Officer Bienstock Lee was granted 1,113,495 shares and covered exercise/tax liability with 214,131 shares, increasing direct ownership by 46% to 2,836,281 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    12/16/25 5:42:25 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    CFO and Treasurer Rosenberg Norman was granted 429,405 shares and covered exercise/tax liability with 65,774 shares, increasing direct ownership by 42% to 1,223,571 units (SEC Form 4)

    4 - DocGo Inc. (0001822359) (Issuer)

    12/16/25 4:16:49 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Leadership Updates

    Live Leadership Updates

    View All

    DocGo Acquires PTI Health To Expand Proactive Healthcare Offering with Mobile Lab Collection and Mobile Phlebotomy Services

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the acquisition of PTI Health, a mid-Atlantic mobile lab collection and phlebotomy services company. This strategic move expands DocGo's healthcare service offering to include mobile phlebotomy lab services, addressing critical gaps in diagnostic care for underserved populations. With this acquisition, DocGo will facilitate timely, convenient blood collection and additional at-home testing services for patients, offering a new level of care to those with limited access to traditional labs or transportation options. The acquisition enhances DocGo's offerings

    2/10/25 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Appoints Healthcare Visionary Dr. Stephen K. Klasko as Chair of the Board

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health services, today announced the appointment of Stephen K. Klasko, M.D., M.B.A as the new independent, non-executive Chair of its Board of Directors, effective October 1, 2024. Dr. Klasko has an extensive background in leadership roles within healthcare, higher education and medical industry innovation, including an eight-year tenure as the President of Thomas Jefferson University and the CEO of Jefferson Health where he oversaw its expansion to 18 hospitals and over 35,000 employees. Prior to that, he was CEO of USF Health and Dean of the Morsani College of Medicine at the University o

    9/30/24 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Appoints Eiwe Lingefors as New Chief Information Officer

    DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-driven healthcare solutions, is proud to announce Eiwe Lingefors as Chief Information Officer (CIO). Lingefors most recently served as the company's Chief Information Security Officer, and will continue in this role as well. In his new role as CIO, Lingefors will lead both DocGo's information security and digital innovation strategy in an evolving cybersecurity landscape. "Eiwe has been a vital part of our team, and his deep expertise in the security landscape has been instrumental in DocGo's operations," said Lee Bienstock, CEO of DocGo. "He has done an excellent job strengthening DocGo's existing cybers

    9/26/24 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Financials

    Live finance-specific insights

    View All

    DocGo Announces Fourth Quarter and Full Year 2025 Results

    Company Raises 2026 Revenue and Adjusted EBITDA Guidance due to Customer Expansions, Improved EMS Hiring Rates and Efficiency Initiatives Company Has Initiated a Formal Process to Explore Strategic Alternatives to Maximize Shareholder Value Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the fourth quarter and full year ended December 31, 2025. Fourth Quarter 2025 Financial Highlights Total revenue for the fourth quarter of 2025 was $74.9 million, compared t

    3/16/26 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo to Announce Fourth Quarter and Full Year 2025 Results on Monday, March 16, 2026

    Management to host conference call and webcast at 5:00 p.m. ET on that day DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled medical transportation and mobile health services, announced today that the Company will release its financial results for the fourth quarter and full year ended December 31, 2025, after the markets close on Monday, March 16, 2025. Management will also host a conference call to discuss these results and its outlook for 2026 at 5:00 p.m. ET on that day. Conference call and webcast details: Monday, March 16, 2026 5:00 p.m. ET 1-800-717-1738 (U.S.) 1-646-307-1865 (international) Conference ID: 74028 To access the Call m

    3/2/26 7:35:00 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    DocGo Announces Third Quarter 2025 Results

    Company Achieves Record Volumes Across All Major Business Lines Management to Host Conference Call and Webcast Today at 5:00 PM Eastern Time DocGo Inc. (NASDAQ:DCGO) ("DocGo" or the "Company"), a leading provider of technology-enabled mobile health and medical transportation services, today announced financial and operating results for the quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights Total revenue for the third quarter of 2025 was $70.8 million, compared to $138.7 million in the third quarter of 2024. This decline was entirely due to the wind-down of migrant-related programs, which generated $8.4 million in the third quarter of 2025 and $80.7 million in

    11/10/25 4:05:00 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    $DCGO
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by DocGo Inc.

    SC 13D/A - DocGo Inc. (0001822359) (Subject)

    11/29/24 4:14:57 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    Amendment: SEC Form SC 13G/A filed by DocGo Inc.

    SC 13G/A - DocGo Inc. (0001822359) (Subject)

    11/14/24 9:56:36 AM ET
    $DCGO
    Medical/Nursing Services
    Health Care

    SEC Form SC 13G/A filed by DocGo Inc. (Amendment)

    SC 13G/A - DocGo Inc. (0001822359) (Subject)

    3/1/24 4:53:15 PM ET
    $DCGO
    Medical/Nursing Services
    Health Care